Name: 5th Annual RAS-Targeted Drug Development Summit
Start: 2023-09-26
End: 2023-09-28
Location: USA

5th Annual RAS-Targeted Drug Development Summit

26
Sep

28
Sep

2023

When

Boston
USA

Where

5th Annual RAS-Targeted Drug Development Summit
Personalizing Medicine Via Targeting Oncogenic RAS for Cancer
With the approval of the second-ever KRAS G12C inhibitor, the field can once again celebrate irrevocable proof that RAS is druggable! However, with so many KRAS G12C drugs in clinic, the field is now turning its eyes to the next generation of RAS therapies, specifically those that can target more mutations, more RAS isoforms, and more indications.
And so, the 5th RAS-Targeted Drug Development Summit arrives as the only industry-dedicated, end-to-end forum to accelerate your best-in-class RAS therapies from conception through to commercialization.
Set to unite 150+ key leaders in biopharma and academia in Boston this September, we are eager to tackle emerging resistance mechanisms, assess promising combination approaches and explore novel RAS therapies.
Hear from 45+ expert speakers across 3 jam-packed days of data-driven presentations, interactive workshops, and panel discussions. This is your one-stop shop to hear the hottest clinical updates, better target non-G12C mutations, validate novel targets in the RAS pathway, and experience the next generation of RAS-targeted drugs.

Why Attend

5th Annual RAS-Targeted Drug Development Summit

Learn innovative strategies, breakthrough research, and novel therapies targeting RAS-driven diseases.

Grow

Expand your knowledge of RAS-driven drug development through cutting-edge presentations, case studies, and scientific discussions. Stay at the forefront of advancements shaping the pharmaceutical industry.

Experience

Witness 3 jam-packed days of data-driven presentations, interactive workshops, and panel discussions. Network with leading researchers, clinicians, and industry professionals. Foster valuable connections and partnerships.

Be inspired

Hear from 45+ expert speakers across 3 jam-packed days of data-driven presentations, interactive workshops, and panel discussions.

Similar Events

Hanson Wade

0/5

(0)

Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.

26 - 28 Sep 2023

In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Jonathan Pachter

Chief Scientific Officer

Verastem

Arjun Balar

Senior Vice President - Global Clinical Development

Loxo Oncology at Lilly

Antreas Hindoyan

Director - Clinical Biomarkers and Diagnostics

Amgen

Chinatsu Sakata-Sakurai

Vice President, Primary Focus Lead Targeted Protein Degradation

Astellas Pharma

Aparajita Chourasia

VP, Biology

BioTheryx

Shohei Koide

Professor of Biologics Design

NYU Langone Health

Hugh Salter

Chief Scientific Officer

Anocca AB

Ali Tavassoli

Chief Scientific Officer

Curve Therapeutics

Terri Conneran

Founder

KRAS Kickers

Saskia Brachmann

Associate Director

Novartis Institutes for BioMedical Research (NIBR)

Allison Zavitz

Lifecycle Leader, KRAS

Roche

Steven Fruchtman

President and CEO

Onconova Therapeutics

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Tempus Labs, Inc.

Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data.

Tempus Labs, Inc.

Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data.

resistanceBio

Helping patients fight treatment resistant cancer. Resistance Bio can discover and overcome clinical treatment resistance pre-clinically.

resistanceBio

Helping patients fight treatment resistant cancer. Resistance Bio can discover and overcome clinical treatment resistance pre-clinically.

Nanome

Nanome is a software company that is changing the way humanity understands and interacts with science. Using Virtual Reality our technology accelerates innovation and understanding in an intuitive manner.

Nanome

Biodesix, Inc.

A leading data-driven diagnostic solutions company helping answer critical clinical questions faced by physicians, researchers, and biopharmaceutical companies, with a primary focus in lung disease.

Biodesix, Inc.

A leading data-driven diagnostic solutions company helping answer critical clinical questions faced by physicians, researchers, and biopharmaceutical companies, with a primary focus in lung disease.

Promega Corporation

At Promega Corporation, creativity and connection drive discovery and innovation. We celebrate scientific discovery and the creative application of science to solve problems.

Promega Corporation

At Promega Corporation, creativity and connection drive discovery and innovation. We celebrate scientific discovery and the creative application of science to solve problems.

Why Attend

5th Annual RAS-Targeted Drug Development Summit